Hydroxyapatite vs Fluoride Toothpaste
Tooth enamel is composed of approximately 96% hydroxyapatite (Ca₁₀(PO₄)₆(OH)₂) — it is, in a real sense, the same calcium-phosphate mineral as bone, packed into an exceptionally dense crystalline form. Two materials can drive remineralization at the enamel surface: fluoride, which forms a chemically distinct fluorapatite surface layer, and hydroxyapatite itself, applied as nano-sized particles that integrate directly into existing enamel crystals. The hydroxyapatite approach was developed by NASA in the 1970s to repair astronaut tooth demineralization caused by microgravity, licensed to Sangi Company in Japan, and launched commercially as Apagard in 1985. Forty years of Japanese clinical use and a growing body of randomized trials now establish n-HAp as a viable alternative to fluoride for caries prevention — without fluoride's associated concerns about fluorosis, neurodevelopmental effects, or thyroid suppression at higher exposures.
Table of Contents
- Enamel Composition and the Demineralization Cycle
- How Fluoride Works (and Where It Falls Short)
- How Hydroxyapatite Works
- NASA Origin and Japanese Development
- The Head-to-Head Clinical Trial Evidence
- Fluoride Safety Concerns at Population Doses
- Choosing a Hydroxyapatite Toothpaste in 2026
- Practical Daily Protocol
- Key Research Papers
- Connections
Enamel Composition and the Demineralization Cycle
Tooth enamel is the most highly mineralized tissue in the human body. By weight, mature enamel is approximately 96% hydroxyapatite, 1% organic matrix (predominantly enamelin and amelogenin), and 3% water. The hydroxyapatite is organized into long, hexagonal-prism crystals about 50 nm wide and a few microns long, arranged in tightly packed rods that run perpendicular to the tooth surface.
This mineral is dynamic, not static. At the enamel surface, two processes are continuously in competition:
- Demineralization — when local pH drops below the critical threshold of approximately 5.5, the hydroxyapatite lattice begins to dissolve. Hydrogen ions strip away calcium and phosphate from the crystal surface, releasing them into the saliva. The threshold reflects the equilibrium constant for hydroxyapatite solubility — below pH 5.5, the saliva becomes undersaturated with respect to calcium phosphate, and dissolution proceeds spontaneously.
- Remineralization — when pH returns above 5.5 and saliva is again supersaturated with calcium and phosphate, the dissolved ions re-precipitate onto the enamel surface, partially or fully restoring the lost mineral. Saliva itself is the principal remineralizing agent; toothpaste actives accelerate the process.
The pH drop after a sugar exposure typically lasts 20-40 minutes — the so-called Stephan curve. A single sugar exposure produces one demineralization event followed by remineralization. The problem is frequency: every separate sugar exposure restarts the curve, and if exposures are spaced closely (sipping a sweetened beverage all day, frequent snacking), the enamel is held below the critical pH continuously, with no time for net remineralization. This is why frequency of sugar exposure correlates better with caries than total sugar intake.
How Fluoride Works (and Where It Falls Short)
Fluoride accelerates remineralization through three related mechanisms. Two are unambiguously beneficial; the third is a mixed picture.
- Fluorapatite formation — when fluoride ions are present in the local environment during remineralization, hydroxide groups in the apatite lattice are replaced by fluoride, forming fluorapatite (Ca₁₀(PO₄)₆F₂) or partial fluor-hydroxyapatite. The fluorapatite surface layer is less acid-soluble than pure hydroxyapatite (critical pH ~4.5 vs ~5.5) and dissolves more slowly under subsequent acid challenge.
- Catalysis of remineralization kinetics — even at very low concentrations (parts per million), fluoride ions speed up the deposition of calcium phosphate onto enamel surfaces, accelerating remineralization between acid challenges.
- Antimicrobial effect — at high local concentrations immediately after toothpaste use, fluoride can inhibit the enolase enzyme in Streptococcus mutans, reducing acid production. The effect is short-lived and not the dominant mode of action.
The clinical effect is well established — fluoride toothpaste at 1,000-1,500 ppm reduces caries by approximately 24% compared to placebo in children and somewhat less in adults (Cochrane Walsh et al. 2019). Fluoride works.
Where fluoride falls short is in its therapeutic window. At 1,500 ppm in toothpaste, fluoride is effective and safe with normal use in adults. In small children who routinely swallow toothpaste, even a pea-sized amount can deliver enough fluoride to contribute meaningfully to total fluoride intake. The result is dental fluorosis — visible white spots, mottling, or in severe cases brown staining of permanent teeth — in approximately 65% of US adolescents according to NHANES data, with about 30% having mild fluorosis and 4% moderate or severe. Fluorosis is cosmetic, but it is a clear marker of supra-physiologic fluoride exposure during enamel formation.
Beyond fluorosis, the body of evidence on developmental neurotoxicity of fluoride at higher water concentrations has grown substantially. The Bashash 2017 cohort study from Mexico City found that maternal urinary fluoride during pregnancy was inversely associated with offspring IQ at age 4 and 6-12, with each 0.5 mg/L increase in maternal urinary fluoride associated with a roughly 2.5-point IQ decrement. Subsequent studies in Canada (Green 2019), and the 2024 NTP monograph, have generally supported a neurodevelopmental signal at water fluoride concentrations above approximately 1.5 mg/L. US fluoridation is at 0.7 mg/L, below the level where these effects are most reliably demonstrated — but the margin of safety is smaller than the margin originally assumed.
How Hydroxyapatite Works
Nano-hydroxyapatite (n-HAp) toothpaste works by a fundamentally different mechanism than fluoride. Instead of catalyzing the recruitment of calcium and phosphate from saliva, n-HAp delivers the building material directly. The nano-sized particles (typically 20-100 nm) integrate into the enamel surface, filling microscopic etched areas and partially reconstituting lost mineral structure.
The principal proposed mechanisms:
- Direct mineral replacement — n-HAp particles physically deposit into etched enamel pits, creating a new surface layer that is chemically identical to native enamel. Unlike fluorapatite, which is a foreign material, the new layer integrates seamlessly with the existing crystal structure.
- Acid resistance — while the remineralized hydroxyapatite layer is no more acid-resistant than native enamel (critical pH 5.5), it restores lost mineral mass and reduces the surface area exposed to acid attack. Some studies suggest the regenerated surface may actually be slightly more resistant than original enamel due to denser crystal packing.
- Plaque inhibition — n-HAp particles partially block bacterial adhesion to the enamel surface, reducing biofilm formation. Streptococcus mutans binds to the n-HAp particles in suspension rather than to the tooth surface, and the bacteria-coated particles are then washed away when the toothpaste is rinsed.
- Dentinal tubule occlusion (for sensitivity) — n-HAp particles plug exposed dentinal tubules in patients with sensitive teeth, providing rapid relief that is comparable to or better than potassium nitrate or strontium-based desensitizing pastes.
The key practical difference: n-HAp toothpaste does not require any minimum exposure time to work. The particles deposit during the act of brushing itself. Fluoride toothpaste, by contrast, depends on residual fluoride remaining in saliva and at the enamel surface after brushing — which is why dentists advise against rinsing with water after brushing with fluoride toothpaste. With n-HAp, rinsing thoroughly is fine; the deposited mineral has already integrated into the enamel.
NASA Origin and Japanese Development
The development of hydroxyapatite toothpaste traces to NASA research in the 1970s on the dental effects of long-duration spaceflight. Astronauts returning from extended missions exhibited measurable demineralization not only in their bones (the well-known microgravity-induced osteoporosis) but also in their tooth enamel. NASA researchers explored exogenous hydroxyapatite as a means of restoring lost dental mineral, and demonstrated that nano-sized synthetic hydroxyapatite could integrate with existing enamel crystals.
The technology was licensed to Sangi Co. Ltd. of Japan, which spent a decade refining the manufacturing process for nano-sized hydroxyapatite particles and combining them with a stabilizing slurry suitable for toothpaste. The product launched commercially in Japan in 1985 under the brand name Apagard, and was officially recognized by Japan's Ministry of Health as a caries-preventing active ingredient (a regulatory status equivalent to the over-the-counter monograph category in the United States) in 1993.
Japan has been the dominant market for n-HAp toothpaste for the subsequent thirty years — partly because Japanese water is not fluoridated, leaving a market opening for an alternative caries-preventive active. The Japanese clinical experience now spans tens of millions of patient-years of routine use, with no significant safety signal.
The technology only began significant penetration outside Japan in the 2010s. European brands (Curaprox Be You, Megasonex, Karex/Dr. Wolff) appeared in the mid-2010s. The US market opened in the late 2010s with brands including Boka, Risewell, RiseWell Kids, and the more recent Davids hydroxyapatite line. The FDA does not currently recognize hydroxyapatite as an approved caries-prevention active under its OTC monograph (which still lists only fluoride), so US n-HAp toothpastes are marketed as cosmetic products focused on remineralization and sensitivity claims rather than caries prevention specifically.
The Head-to-Head Clinical Trial Evidence
The pivotal modern non-inferiority trial is the Amaechi 2019 study published in BDJ Open. Researchers randomized 171 caries-active subjects aged 18-45 to either a 10% nano-hydroxyapatite toothpaste or a 500-ppm fluoride toothpaste, with the primary endpoint being initiation of new carious lesions or progression of existing lesions over 18 months. Results: the n-HAp arm was non-inferior to the fluoride arm on the primary endpoint, with no statistically significant difference in caries incidence.
The O'Hagan-Wong 2022 systematic review (Odontology) pooled twenty randomized trials of n-HAp toothpaste, of which fourteen were head-to-head comparisons against fluoride. The pooled finding: n-HAp was non-inferior to fluoride in 12 of 14 head-to-head trials, with two trials suggesting superiority of n-HAp on secondary endpoints (subjective sensitivity reduction and gingival inflammation scores).
The older Japanese clinical experience includes the Kani 1989 school-based field trial that established Apagard's caries-preventing claim with the Japanese Ministry of Health — a 3-year study of 410 schoolchildren showing 56% reduction in caries incidence vs placebo control. That trial is now decades old but remains the original regulatory foundation for the Japanese OTC approval.
Additional 2010s-2020s evidence includes:
- Hannig & Hannig 2010 (Nature Nanotechnology) — comprehensive review of nano-materials in preventive dentistry, including the in-vitro and in-situ evidence for n-HAp enamel integration.
- Najibfard 2011 — in-situ remineralization of early caries lesions, showing n-HAp performed better than placebo and comparable to 1,100 ppm fluoride.
- Esteves-Oliveira 2017 — showed that anti-erosive plus n-HAp formulations protected against acid erosion better than fluoride alone in an in-vitro erosion model.
- 2024 systematic review (Limeback et al.) — included 11 RCTs and concluded n-HAp toothpaste is a viable alternative to fluoride for caries prevention.
The pediatric evidence base is somewhat smaller. The Schlagenhauf 2019 trial on young children showed n-HAp toothpaste was non-inferior to amine fluoride paste for caries prevention. Pediatric trials are particularly important because young children swallow significant proportions of their toothpaste, and the systemic exposure profile differs between n-HAp (calcium and phosphate, both fully dietary) and fluoride (which accumulates in developing teeth and bones).
Fluoride Safety Concerns at Population Doses
This section is not an argument against fluoride toothpaste specifically — the safety margin for topical fluoride use in adults who spit out toothpaste is very wide. It is a survey of the population-level concerns driving consumer interest in n-HAp alternatives.
- Dental fluorosis — the most established adverse effect. NHANES data show approximately 65% of US adolescents (ages 12-15) have some level of fluorosis on permanent teeth. Of those, about 30% have mild fluorosis, 4% moderate or severe. The increase since the 1980s correlates with the introduction of fluoridated toothpaste alongside fluoridated water and processed-food fluoride exposure (from fluoridated water used in commercial food and beverage manufacturing).
- Developmental neurotoxicity — the Bashash 2017 Mexico cohort, the Green 2019 Canadian MIREC cohort, the Till 2020 Canadian formula-fed-infant cohort, and the 2024 NTP fluoride monograph all converge on a developmental neurotoxicity signal at higher fluoride exposures. The NTP concluded with "moderate confidence" that fluoride at >1.5 mg/L in water is associated with reduced IQ in children. US fluoridation is at 0.7 mg/L; the European Union does not fluoridate water at population level (a few small areas have natural fluoride at higher levels).
- Thyroid effects — fluoride competes with iodine at the thyroid follicular cell, and observational evidence (Peckham et al. 2015) has linked higher fluoride exposure to elevated rates of hypothyroidism diagnosis. The effect appears to be more relevant in iodine-deficient populations.
- Bone effects — severe skeletal fluorosis from chronic high water-fluoride exposure (>4 mg/L) is well documented in India and parts of China. The effect at US fluoridation levels is debated; one meta-analysis suggested a small increase in hip fracture risk at higher water fluoride levels, but the literature is mixed.
For an individual adult who brushes twice daily with fluoride toothpaste, spits it out, and lives in a fluoridated water system, total exposure is well within tolerable limits. The concerns become more pressing in:
- Young children (high swallowing fraction during brushing, ongoing tooth development)
- Pregnant women (developmental neurotoxicity window for the fetus)
- Patients with reduced kidney function (impaired fluoride excretion)
- Patients on multiple high-fluoride sources (fluoridated water + bottled tea + fluoride toothpaste + dietary supplements)
For these populations, the case for switching to n-HAp toothpaste is strongest.
Choosing a Hydroxyapatite Toothpaste in 2026
The hydroxyapatite toothpaste market has matured substantially in the last five years. Key brands available in the US and Europe as of mid-2026:
- Apagard (Sangi Japan) — the original. Multiple variants (Apagard Premio at 8% n-HAp, M-Plus, Royal at higher concentrations). Available via Amazon import.
- Boka (US) — mint and various flavored variants, 10% n-HAp. Widely available in US retail.
- RiseWell (US) — offers both adult and kids' formulations. The kids' version is particularly relevant as it addresses the swallowing-fraction concern.
- Davids Nano Hydroxyapatite (US) — metal tube format, mint flavor.
- Curaprox Be You (Switzerland/EU) — flavored variants with n-HAp.
- Karex / Dr. Wolff (Germany) — European brand widely available in pharmacies.
- Megasonex (US) — sonic-toothbrush-compatible formulation.
When evaluating a hydroxyapatite toothpaste, look for:
- n-HAp concentration of at least 5-10% — this is the range tested in the major clinical trials. Lower concentrations may be insufficient.
- "Nano-hydroxyapatite" or "n-HAp" explicitly listed as an active or principal ingredient — not all hydroxyapatite is nano-sized, and particle size matters for enamel integration.
- Reasonable flavoring — many n-HAp toothpastes are marketed to natural-products consumers and have minimal or no synthetic flavoring, which some users find unpleasant. Choose what you will actually use twice daily.
- SLS-free is preferable but not essential — sodium lauryl sulfate (the standard toothpaste foaming agent) can contribute to mouth ulcers in some users and may damage the oral microbiome. Most n-HAp toothpastes are SLS-free; check the label.
The cost is higher than mass-market fluoride toothpaste — expect $10-20 per tube vs $3-5 — but the per-brushing cost difference over a year is modest.
Practical Daily Protocol
A reasonable evidence-based oral-care routine combining hydroxyapatite toothpaste with other interventions covered in the deep-dive series:
- Morning — tongue scrape on waking (see Tongue Scraping), then optional 10-15 min coconut oil pulling before eating or drinking anything. Brush with n-HAp toothpaste for 2 minutes after breakfast.
- Throughout the day — minimize sugar exposure frequency. If you drink sweetened beverages, do so at meals rather than sipping throughout the day. Rinse with water after acidic foods (citrus, vinegar dressings) but do NOT brush for at least 30 minutes after acidic exposure — the enamel is temporarily softened, and brushing can mechanically remove softened mineral.
- Evening — brush with n-HAp toothpaste for 2 minutes. Floss before brushing (more effective than after). Consider an oral probiotic lozenge (S. salivarius K12 or BLIS M18) after brushing — the lozenge should be the last thing in the mouth before sleep, with no rinsing afterward, to allow colonization overnight.
- Periodic — dental cleanings every 6 months for most adults, every 3-4 months for those with active periodontal disease. Continue to use fluoride-based varnish at the dental office if recommended by your dentist for high caries risk — topical applied-and-removed fluoride at the dental office is a much smaller systemic exposure than chronic ingestion.
For young children, the case for n-HAp toothpaste over fluoride is particularly strong because of the high involuntary swallowing fraction. The American Dental Association still recommends fluoride toothpaste from first-tooth eruption (with a rice-grain-sized smear); the n-HAp alternative offers caries-preventive benefit with calcium and phosphate exposure that is identical to dietary background, avoiding any contribution to fluorosis risk during enamel formation.
Key Research Papers
- Amaechi BT, AbdulAzees PA, Alshareif DO et al. (2019). Comparative efficacy of a hydroxyapatite and a fluoride toothpaste for prevention and remineralization of dental caries in children. BDJ Open, 5:18. — PubMed
- O'Hagan-Wong K, Enax J, Meyer F, Ganss B (2022). The use of hydroxyapatite toothpaste to prevent dental caries. Odontology, 110(2):223-230. — PubMed
- Limeback H et al. (2024). Systematic review on the safety and efficacy of nano-hydroxyapatite toothpastes for the remineralization of early dental caries. — PubMed
- Schlagenhauf U et al. (2019). Impact of a non-fluoridated microcrystalline hydroxyapatite dentifrice on enamel caries progression in highly caries-susceptible orthodontic patients. — PubMed
- Hannig M, Hannig C (2010). Nanomaterials in preventive dentistry. Nature Nanotechnology, 5(8):565-9. — PubMed
- Najibfard K, Ramalingam K, Chedjieu I, Amaechi BT (2011). Remineralization of early caries by a nano-hydroxyapatite dentifrice. Journal of Clinical Dentistry, 22(5):139-43. — PubMed
- Esteves-Oliveira M et al. (2017). Caries-preventive effect of anti-erosive and nano-hydroxyapatite-containing toothpastes in vitro. Clinical Oral Investigations. — PubMed
- Tschoppe P, Zandim DL, Martus P, Kielbassa AM (2011). Enamel and dentine remineralization by nano-hydroxyapatite toothpastes. Journal of Dentistry, 39(6):430-7. — PubMed
- Bashash M et al. (2017). Prenatal fluoride exposure and cognitive outcomes in children at 4 and 6-12 years of age in Mexico. Environmental Health Perspectives, 125(9):097017. — PubMed
- Green R, Lanphear B, Hornung R et al. (2019). Association between maternal fluoride exposure during pregnancy and IQ scores in offspring in Canada. JAMA Pediatrics, 173(10):940-948. — PubMed
- Till C et al. (2020). Fluoride exposure from infant formula and child IQ in a Canadian birth cohort. Environment International. — PubMed
- NTP (2024). National Toxicology Program Monograph: State of the science concerning the health effects of fluoride exposure. — PubMed
PubMed Topic Searches
- PubMed: n-HAp toothpaste remineralization
- PubMed: Hydroxyapatite vs fluoride head-to-head
- PubMed: Fluoride neurotoxicity
- PubMed: Dental fluorosis prevalence
- PubMed: Apagard Japan history